Abstract
PRRT2-associated paroxysmal movement disorders (PRRT2-PxMDs) include paroxysmal kinesigenic dyskinesias (PKD), benign familial infantile epilepsy (BFIE), infantile convulsions and choreoathetosis (ICCA), episodic ataxia (EA), paroxysmal nonkinesiasgenic dyskinesias (PNKD), and, in addition, other childhood-onset movement disorders and different types of seizures may be caused by PRRT2 mutations, suggesting that the understanding of the spectrum of PRRT2-PxMDs is still evolving. We collected and analyzed retrospectively the clinical of children diagnosed with paroxysmal movement disorders by the Department of Neurology of Anhui Provincial Children's Hospital from January 2015 to June 2020. The genetic tests were performed in the probands and their family members. Thirteen children and their family members, 30 in total, were tested. Twenty six patients and 4 (13.34%) carriers from 13 families were identified, 14 (46.67%) were diagnosed with BIE, 7 (23.33%) with PKD, 2 (6.67%) with ICCA, 1 (3.33%) with epilepsy (focal), 1 (3.33%) with infantile spasm (IS), and 1 (3.33%)was diagnosed with PKD and PNKD, Eight different variants were identified in 13 families, and NM_145239.2:c.640-641insC was found in 4 families while recurrent mutation c.649dupC was not found. Three novel mutation, c.884G > C, c.865G > C, and c.-65-1G > C were identified in this study. This study confirmed that there is no clear genotype-phenotype correlation in patients with PRRT2-PxMDs, in addition, the clinical findings show variable phenotype within families, including the families affected due to the newly identified pathogenic variants in this study.